Summary
- Current Price
- As of today, VTGN price is $0.54, down -0.52% on
- Current Price All-Time High
- VTGN price is currently -99.97% below its historical high of $1,890.00 set on
- Market Cap
- VTGN current market cap is $21M, down -67.88% year-over-year
- PE Ratio
- VTGN PE ratio is unknown
- Revenue
- VTGN current annual revenue is $486.00K, down -54.32% year-over-year
- Next Earnings
- The next earnings release for VTGN is on
Profile
| Metric | Value |
|---|---|
| Full Name | Vistagen Therapeutics, Inc. |
| Ticker | NASDAQ: VTGN |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | vistagen.com |
| Employees | 56 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $0.54 | ||
| Price, 1D Change | -0.52% | |
| $21M | ||
| - | ||
| - | ||
| 2.03 | ||
| $486K | ||
| Revenue, 1Y Change | -54.32% | |
| -$1.67 | ||
| EPS, 1Y Change | -9.76% |
Chart
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:30 | |
| Next Split | N/A | N/A |
| Last Ticker Change | VSTA | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$1.67 | ||
| EPS Estimate | -$1.71 | |
| EPS Est. Change | -2.89% | |
| $486.00K | ||
| Revenue Estimate | $1.03M | |
| Revenue Est. Change | +110.91% | |
| $0.54 | ||
| Price Target | - | $1.00 |
| Price Tgt. Change | - | +86.15% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.60 | -$1.52 | +5.18% | |
| -$1.74 | -$1.67 | +4.02% | |
| -$1.71 | N/A | -2.89% | |
| -$0.98 | N/A | +41.35% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $1.06M | $1.06M | +0.38% | |
| $710.00K | $486.00K | -31.55% | |
| $1.03M | N/A | +110.91% | |
| $250.00K | N/A | -48.56% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| -77.04% | ||
| -74.78% | ||
| -67.88% | ||
| +36.68% | ||
| -54.32% | ||
| -56.17% | ||
| -9.76% | ||
| +77.44% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Date | Value |
|---|---|---|
| $0.54 | ||
| $1.95 | ||
| $0.60 | ||
| $1.48 | ||
| $0.64 | ||
| -$0.01 | ||
| 2.03 | ||
| $0.05 | ||
| 37.62 | ||
| 71.20% | ||
| 112.00% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $486.00K | ||
| -$1.67 | ||
| -$149.00K | ||
| -30.66% | ||
| -$55.97M | ||
| -11.52% | ||
| -$51.42M | ||
| -10.58% | ||
| -$55.34M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.02 | ||
| 6.51 | ||
| 6.51 | ||
| - | ||
| 3 | ||
| -7.05 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 26.94 | ||
| 0.42 | ||
| 0.56 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $70.39M | ||
| $80.48M | ||
| $84.34M | ||
| $82.08M | ||
| $13.95M | ||
| $12.61M | ||
| $1.51M | ||
| $561.00K | ||
| $653.00K |
Expenses
| Metric | Date | Value |
|---|---|---|
| $51.90M | ||
| $55.82M | ||
| $635.00K | ||
| $0.00 | ||
| $635.00K | ||
| $0.00 | ||
| $7,000.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$42.10M | ||
| -$13.15M | ||
| $3.21M | ||
| $191.00K | ||
| -$42.29M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| William Blair | → | |
| Maxim Group | → | |
| Jefferies | → | |
| Jefferies | → | |
| Stifel | ||
| Maxim Group | → | |
| Maxim Group | → | |
| Maxim Group | → | |
| William Blair | → | |
| Baird |
Analyst sentiment
Institutional ownership
Screeners with VTGN
FAQ
What is the ticker symbol for Vistagen Therapeutics, Inc.?
The ticker symbol for Vistagen Therapeutics, Inc. is NASDAQ:VTGN
Does Vistagen Therapeutics, Inc. pay dividends?
No, Vistagen Therapeutics, Inc. does not pay dividends
What sector is Vistagen Therapeutics, Inc. in?
Vistagen Therapeutics, Inc. is in the Healthcare sector
What industry is Vistagen Therapeutics, Inc. in?
Vistagen Therapeutics, Inc. is in the Biotechnology industry
What country is Vistagen Therapeutics, Inc. based in?
Vistagen Therapeutics, Inc. is headquartered in United States
When did Vistagen Therapeutics, Inc. go public?
Vistagen Therapeutics, Inc. initial public offering (IPO) was on June 21, 2011
Is Vistagen Therapeutics, Inc. in the S&P 500?
No, Vistagen Therapeutics, Inc. is not included in the S&P 500 index
Is Vistagen Therapeutics, Inc. in the NASDAQ 100?
No, Vistagen Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Vistagen Therapeutics, Inc. in the Dow Jones?
No, Vistagen Therapeutics, Inc. is not included in the Dow Jones index
When was Vistagen Therapeutics, Inc. last earnings report?
Vistagen Therapeutics, Inc.'s most recent earnings report was on February 12, 2026
When does Vistagen Therapeutics, Inc. report earnings?
The next expected earnings date for Vistagen Therapeutics, Inc. is June 16, 2026
Data Sources & References
- VTGN Official Website www.vistagen.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1411685/000162828026007718/0001628280-26-007718-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1411685/000141168525000041/0001411685-25-000041-index.htm
- VTGN Profile on Yahoo Finance finance.yahoo.com/quote/VTGN
- VTGN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/vtgn